Extra-intestinal manifestations of Crohn's disease.

[1]  A. Forbes,et al.  Respiratory symptoms in patients with inflammatory bowel disease and the impact of dietary salicylates. , 2007, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[2]  S. Plevy,et al.  Treatment of immune-mediated extraintestinal manifestations of inflammatory bowel disease with infliximab. , 2006, Gastroenterology clinics of North America.

[3]  R. Gaykema,et al.  Induction of anxiety-like behavior in mice during the initial stages of infection with the agent of murine colonic hyperplasia Citrobacter rodentium , 2006, Physiology & Behavior.

[4]  S. Mannor,et al.  Abnormalities of uterine cervix in women with inflammatory bowel disease. , 2006, World journal of gastroenterology.

[5]  E. Stange.  Review article: the effect of aminosalicylates and immunomodulation on cancer risk in inflammatory bowel disease , 2006, Alimentary pharmacology & therapeutics.

[6]  J. Andrews,et al.  Antidepressants and inflammatory bowel disease: a systematic review , 2006, Clinical practice and epidemiology in mental health : CP & EMH.

[7]  C. Bernstein.  Inflammatory bowel diseases as secondary causes of osteoporosis , 2006, Current osteoporosis reports.

[8]  E. Stange,et al.  Extraintestinal manifestations and complications in inflammatory bowel diseases. , 2006, World journal of gastroenterology.

[9]  S. Danese,et al.  Etiopathogenesis of inflammatory bowel diseases. , 2006, World journal of gastroenterology.

[10]  E. Fuller-Thomson,et al.  Depression and inflammatory bowel disease: Findings from two nationally representative Canadian surveys , 2006, Inflammatory bowel diseases.

[11]  B. Größner-Schreiber,et al.  Prevalence of dental caries and periodontal disease in patients with inflammatory bowel disease: a case-control study. , 2006, Journal of clinical periodontology.

[12]  E. Zimlichman,et al.  Autoimmune Diseases in Asthma , 2006, Annals of Internal Medicine.

[13]  A. Bron,et al.  Corneal Perforation Due to Severe Peripheral Ulcerative Keratitis in Crohn Disease , 2006, Cornea.

[14]  Phoebe Lin,et al.  Family history of inflammatory bowel disease in patients with idiopathic ocular inflammation. , 2006, American journal of ophthalmology.

[15]  A. Ensari,et al.  Behçet's disease‐like presentation of bullous pyoderma gangrenosum associated with Crohn's disease , 2006, Clincal and Experimental Dermatology.

[16]  F. Frizelle,et al.  Inflammatory bowel disease and the lung: is there a link between surgery and bronchiectasis? , 2006, International Journal of Colorectal Disease.

[17]  V. Rousson,et al.  Analysis of Risk Factors for Low Bone Mineral Density in Inflammatory Bowel Disease , 2006, Digestion.

[18]  A. Forbes,et al.  Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial , 2005, Gut.

[19]  E. Szigethy,et al.  Psychosocial functioning in pediatric inflammatory bowel disease , 2006, Inflammatory bowel diseases.

[20]  D. Visscher,et al.  Bronchiolitis: the pathologist's perspective. , 2006, Proceedings of the American Thoracic Society.

[21]  X. Hou,et al.  Retrospective survey of 452 patients with inflammatory bowel disease in Wuhan City, central China , 2006, Inflammatory bowel diseases.

[22]  L. Pizzi,et al.  Impact of chronic conditions on quality of life in patients with inflammatory bowel disease , 2006, Inflammatory bowel diseases.

[23]  R. Hubbard,et al.  Risk of schizophrenia in people with coeliac disease, ulcerative colitis and Crohn's disease: a general population‐based study , 2006, Alimentary pharmacology & therapeutics.

[24]  H. L. Young,et al.  Metastatic Cutaneous Crohn's Disease of the Nipple: Report of a Case , 2006, Diseases of the Colon & Rectum.

[25]  S. Katz.  Osteoporosis in patients with inflammatory bowel disease: risk factors, prevention, and treatment. , 2006, Reviews in gastroenterological disorders.

[26]  A. Gasbarrini,et al.  Early atherosclerosis in patients with inflammatory bowel disease. , 2006, European review for medical and pharmacological sciences.

[27]  M. Toruner,et al.  The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease , 2006, Rheumatology International.

[28]  M. Zali,et al.  Bone mineral density in Iranian patients with inflammatory bowel disease , 2006, International Journal of Colorectal Disease.

[29]  C. Bernstein,et al.  The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study. , 2005, Gastroenterology.

[30]  J. Braun,et al.  Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept. , 2005, Arthritis and rheumatism.

[31]  A. Gottlieb,et al.  Infliximab induction therapy for patients with severe plaque-type psoriasis: a randomized, double-blind, placebo-controlled trial. , 2004, Journal of the American Academy of Dermatology.

[32]  Samir A. Shah,et al.  Ocular Manifestations of Inflammatory Bowel Disease , 2004, Inflammatory bowel diseases.

[33]  P. Lakatos,et al.  Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year follow-up study. , 2003, World journal of gastroenterology.

[34]  F. Seibold,et al.  Response of cutaneous Crohn's disease to infliximab and methotrexate. , 2003, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[35]  D. Baeten,et al.  Ankylosing spondylitis and bowel disease. , 2002, Best practice & research. Clinical rheumatology.

[36]  Nancy Xiaonan Yu,et al.  The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study , 2001, American Journal of Gastroenterology.

[37]  M. Vos,et al.  Crohn's disease associated with spondyloarthropathy: effect of TNF-α blockade with infliximab on articular symptoms , 2000, The Lancet.

[38]  H. Watts,et al.  National Cooperative Crohn's Disease Study: extraintestinal manifestations and perianal complications. , 1979, Gastroenterology.